Back to OCULView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Post Ocular Surgical Inflammation and Pain
View Full LandscapeDrug Information
Target Indication
Post Ocular Surgical Inflammation and Pain
Clinical Trial
NCT02034019Last updated: 12/4/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Ophthalmic InsertPhase 3
Open Angle Glaucoma and Ocular Hypertension
Dextenza Ophthalmic InsertPhase 3
Cataract
OTX-TKI (axitinib implant)Phase 3
Neovascular Age-Related Macular Degeneration
Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24Phase 3
Non-Proliferative Diabetic Retinopathy
TravoprostPhase 3
Open Angle Glaucoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts